Targeting fatty lipids known as ceramides could reverse insulin resistance and fatty liver, scientists from the University of Utah and Merck Research Laboratories discovered. They've shown in mice they can accomplish that by shifting two hydrogen atoms, and now they're searching for drugs that can accomplish the same feat.
